FDA/CMS Formal Collaboration Will Include Data Sharing, Parallel Review
This article was originally published in The Pink Sheet Daily
Executive Summary
A draft memorandum of understanding is under review at both agencies, Centers for Medicare & Medicaid Services Chief Medical Officer Sean Tunis, MD, told the BIO annual meeting in San Francisco. The MOU will address parallel review for new technologies, and allow the agencies to share scientific expertise and data.